| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
| filingDate |
2004-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94d35f5f213602e95ce1c57b01145e87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7efb5bc063476caaddf8719cba04e613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09d98cc3436bf88f886d2c22d45cefda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_948c405bdd01dc7ffa98dbf51f5f5501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9d067beff8aa9a814e7e9d6b825a4a |
| publicationDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2357734-C2 |
| titleOfInvention |
COMBINATION OF mGluR2 RECEPTOR ANTAGONIST AND AChE ENZYME INHIBITOR FOR ACUTE ANDN/OR CHRONIC NEURALGIC DISEASES |
| abstract |
FIELD: medicine. n SUBSTANCE: invention concerns medicine and claims method of acute and/or chronic neuralgic disorder or disturbance treatment and/or prevention, pharmaceutical composition including acetylcholinesterase inhibitor (AChE enzyme inhibitor) and metabotropic glutamate receptor 2 antagonist (mGluR2 receptor antagonist), application of AChE enzyme inhibitor and mGluR2 receptor antagonist in obtaining medicine, and combinations including AChE enzyme inhibitor and mGluR2 receptor antagonist. n EFFECT: synergetic effect of AChE enzyme inhibitor and mGluR2 receptor antagonist combination for treatment of acute and chronic neuralgic disorders or disturbances. n 13 cl, 7 dwg |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2472475-C2 |
| priorityDate |
2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |